Deliberations on drug-related lawsuits have reached a climax, and Yabuta Pharmaceutical is losing the lawsuit. After learning that medical professor Mizushima will appear in court as a witness for the plaintiff, the Yabuta Group asks the professor to stop giving unfavorable testimony.
